Jim Simons’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,742
| Closed | -$19K | – | 3996 |
|
|
2024
Q2 | $19K | Sell |
28,742
-28,599
| -50% | -$17.8K | ﹤0.01% | 3388 |
|
|
2024
Q1 | $35K | Sell |
57,341
-9,501
| -14% | -$5.82K | ﹤0.01% | 3537 |
|
|
2023
Q4 | $39K | Buy |
66,842
+39,500
| +144% | +$23.8K | ﹤0.01% | 3498 |
|
|
2023
Q3 | $18K | Buy |
+27,342
| New | +$33.5K | ﹤0.01% | 3532 |
|
|
2023
Q2 | – | Sell |
-26,647
| Closed | -$242K | – | 4362 |
|
|
2023
Q1 | $242K | Buy |
26,647
+3,766
| +16% | +$53.4K | ﹤0.01% | 3201 |
|
|
2022
Q4 | $268K | Sell |
22,881
-7,652
| -25% | -$135K | ﹤0.01% | 3276 |
|
|
2022
Q3 | $647K | Buy |
30,533
+4,216
| +16% | +$114K | ﹤0.01% | 2762 |
|
|
2022
Q2 | $638K | Buy |
26,317
+20,580
| +359% | +$700K | ﹤0.01% | 3003 |
|
|
2022
Q1 | $286K | Buy |
+5,737
| New | +$283K | ﹤0.01% | 3491 |
|
|
2020
Q3 | – | Sell |
-7,163
| Closed | -$666K | – | 3772 |
|
|
2020
Q2 | $666K | Sell |
7,163
-4,264
| -37% | -$235K | ﹤0.01% | 2756 |
|
|
2020
Q1 | $326K | Buy |
+11,427
| New | +$444K | ﹤0.01% | 2945 |
|
|
2018
Q4 | – | Sell |
-2,140
| Closed | -$155K | – | 3676 |
|
|
2018
Q3 | $155K | Buy |
+2,140
| New | +$141K | ﹤0.01% | 3193 |
|
|
2018
Q1 | – | Sell |
-3,050
| Closed | -$391K | – | 3628 |
|
|
2017
Q4 | $391K | Buy |
+3,050
| New | +$375K | ﹤0.01% | 2940 |
|
|
2016
Q4 | – | Sell |
-473
| Closed | -$49K | – | 3511 |
|
|
2016
Q3 | $49K | Buy |
+473
| New | +$53.1K | ﹤0.01% | 3255 |
|
Jim Simons's VBIV Position: Q3 2024 in Review
Jim Simons sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 28,742 shares — an estimated $19K sold.
Jim Simons first reported a position in VBIV in Q3 2016 and held it in 14 quarters. The position peaked at $666K in Q2 2020. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Jim Simons reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Jim Simons sold 28,742 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $19K.
- Jim Simons first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2016 and held it in 14 quarters.
- Jim Simons's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $666K in Q2 2020.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.